| 1 | 17676365 | Tempo and mode in the endocannaboinoid system. | J Mol Evol | 2007 Sep |
1 |
| 2 | 17704825 | GPR55 and the vascular receptors for cannabinoids. | Br J Pharmacol | 2007 Nov |
2 |
| 3 | 17704827 | The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. | Br J Pharmacol | 2007 Nov |
1 |
| 4 | 17876300 | GPR55: a new member of the cannabinoid receptor clan? | Br J Pharmacol | 2007 Dec |
10 |
| 5 | 17906678 | Novel cannabinoid receptors. | Br J Pharmacol | 2007 Nov |
2 |
| 6 | 18502582 | The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. | Pain | 2008 Sep 30 |
1 |
| 7 | 19286662 | Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. | J Biol Chem | 2009 May 1 |
2 |
| 8 | 19464294 | Differential changes in GPR55 during microglial cell activation. | FEBS Lett | 2009 Jun 18 |
2 |
| 9 | 19805329 | The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. | Proc Natl Acad Sci U S A | 2009 Sep 22 |
4 |
| 10 | 20298715 | Pharmacological characterization of GPR55, a putative cannabinoid receptor. | Pharmacol Ther | 2010 Jun |
6 |
| 11 | 21358974 | Cannabinoid receptors as target for treatment of osteoporosis: a tale of two therapies. | Curr Neuropharmacol | 2010 Sep |
3 |
| 12 | 21744421 | The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. | Inflamm Bowel Dis | 2011 Aug |
4 |
| 13 | 21885477 | A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. | J Endocrinol | 2011 Nov |
2 |
| 14 | 21981246 | The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats. | Diabetes Obes Metab | 2012 Mar |
3 |
| 15 | 22751111 | The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas. | Oncogene | 2013 May 16 |
2 |
| 16 | 22759743 | Evidence for the putative cannabinoid receptor (GPR55)-mediated inhibitory effects on intestinal contractility in mice. | Pharmacology | 2012 |
3 |
| 17 | 22850623 | Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice. | Pancreas | 2013 Jan |
7 |
| 18 | 23565223 | GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination. | PLoS One | 2013 |
5 |
| 19 | 23603203 | A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice. | Neuropharmacology | 2013 Aug |
1 |
| 20 | 23973358 | A novel biological role for the phospholipid lysophosphatidylinositol in nociceptive sensitization via activation of diverse G-protein signalling pathways in sensory nerves in vivo. | Pain | 2013 Dec |
1 |
| 21 | 23992544 | Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice. | Br J Pharmacol | 2013 Nov |
7 |
| 22 | 24130809 | Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis. | PLoS One | 2013 |
2 |
| 23 | 24964851 | [Role of orphan G protein-coupled receptor 55 in diabetic gastroparesis in mice]. | Sheng Li Xue Bao | 2014 Jun 25 |
4 |
| 24 | 25205418 | Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent. | Br J Pharmacol | 2015 Jan |
1 |
| 25 | 25275556 | GPR55 deletion in mice leads to age-related ventricular dysfunction and impaired adrenoceptor-mediated inotropic responses. | PLoS One | 2014 |
1 |
| 26 | 26227635 | The GPR55 antagonist CID16020046 protects against intestinal inflammation. | Neurogastroenterol Motil | 2015 Oct |
6 |
| 27 | 26236485 | Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach. | Pharmacol Res Perspect | 2015 Jun |
1 |
| 28 | 26730399 | Role of GPR55 during Axon Growth and Target Innervation. | eNeuro | 2015 Sep-Oct |
6 |
| 29 | 26971034 | The effect of O-1602, an atypical cannabinoid, on morphine-induced conditioned place preference and physical dependence. | Pharmacol Rep | 2016 Jun |
1 |
| 30 | 27186076 | Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent. | Breast Cancer (Dove Med Press) | 2016 |
1 |
| 31 | 27465665 | Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis. | Thromb Haemost | 2016 Oct 28 |
5 |
| 32 | 27561953 | GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans. | Diabetes Obes Metab | 2016 Dec |
8 |
| 33 | 27677765 | Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice. | Diabetologia | 2016 Dec |
3 |
| 34 | 28064014 | GPR55 agonist lysophosphatidylinositol and lysophosphatidylcholine inhibit endothelial cell hyperpolarization via GPR-independent suppression of Na<sup>+</sup>-Ca<sup>2+</sup> exchanger and endoplasmic reticulum Ca<sup>2+</sup> refilling. | Vascul Pharmacol | 2017 Feb |
1 |
| 35 | 28373843 | Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral-Induced Neuropathic Pain. | Front Pharmacol | 2017 |
2 |
| 36 | 28638091 | The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice. | Sci Rep | 2017 Jun 21 |
1 |
| 37 | 28653801 | A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity. | Hippocampus | 2017 Sep |
9 |
| 38 | 28779174 | A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum. | Sci Rep | 2017 Aug 4 |
1 |
| 39 | 28800762 | The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress. | Mol Brain | 2017 Aug 11 |
2 |
| 40 | 28875496 | G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1. | Int J Cancer | 2018 Jan 1 |
4 |
| 41 | 28973916 | Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome. | Proc Natl Acad Sci U S A | 2017 Oct 17 |
2 |
| 42 | 29205751 | LH-21 and abnormal cannabidiol improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling. | Diabetes Obes Metab | 2018 Apr |
3 |
| 43 | 29225068 | Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner. | Mol Cell Endocrinol | 2018 Sep 5 |
4 |
| 44 | 30056123 | Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome. | Neuropharmacology | 2018 Sep 15 |
1 |
| 45 | 30061636 | GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. | Oncogene | 2018 Dec |
5 |
| 46 | 30148676 | GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues. | FASEB J | 2019 Jan |
5 |
| 47 | 30243065 | Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB<sub>2</sub> and GPR55 receptor activation. Possible involvement of CB<sub>2</sub>-GPR55 heteromers. | Int Immunopharmacol | 2018 Nov |
1 |
| 48 | 30354245 | Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation. | Arterioscler Thromb Vasc Biol | 2018 Nov |
4 |
| 49 | 30550613 | Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure. | Invest Ophthalmol Vis Sci | 2018 Dec 3 |
1 |
| 50 | 30830860 | GPR55 controls functional differentiation of self-renewing epithelial progenitors for salivation. | JCI Insight | 2019 Feb 21 |
1 |